Cargando…

Antiestrogens: structure-activity relationships and use in breast cancer treatment

About 70% of breast tumors express estrogen receptor alpha (ERα), which mediates the proliferative effects of estrogens on breast epithelial cells, and are candidates for treatment with antiestrogens, steroidal or non-steroidal molecules designed to compete with estrogens and antagonize ERs. The var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Traboulsi, T, El Ezzy, M, Gleason, J L, Mader, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148801/ https://www.ncbi.nlm.nih.gov/pubmed/27729460 http://dx.doi.org/10.1530/JME-16-0024

Ejemplares similares

OR11-02 Structural Determinants of Pure Antiestrogenic Activity
por: Vallet, Amandine, et al.
Publicado: (2023)

The AF-2 cofactor binding region is key for the selective SUMOylation of estrogen receptor alpha by antiestrogens
por: Vallet, Amandine, et al.
Publicado: (2022)

Role of SUMOylation in differential ERα transcriptional repression by tamoxifen and fulvestrant in breast cancer cells
por: Traboulsi, Tatiana, et al.
Publicado: (2018)

Combination of Antiestrogens and Omega-3 Fatty Acids for Breast Cancer Prevention
por: Manni, Andrea, et al.
Publicado: (2015)

Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments
por: Ao, Ada, et al.
Publicado: (2011)

The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer
por: Schwartz, J. L., et al.
Publicado: (2011)

Estrogenic or antiestrogenic therapies for multiple myeloma?
por: Sola, Brigitte, et al.
Publicado: (2007)

The Role of Long Noncoding RNAs in Antiestrogen Resistance in Breast Cancer: An Overview and Update
por: Huang, Lan, et al.
Publicado: (2020)

The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance
por: Suba, Zsuzsanna
Publicado: (2015)

A Closer Look at Estrogen Receptor Mutations in Breast Cancer and Their Implications for Estrogen and Antiestrogen Responses
por: Clusan, Léa, et al.
Publicado: (2021)

Screening for estrogenic and antiestrogenic activities of plants growing in Egypt and Thailand
por: El-Halawany, Ali M., et al.
Publicado: (2011)

Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers
por: Linares, Aurélien, et al.
Publicado: (2019)

ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
por: Kalyuga, Maria, et al.
Publicado: (2012)

Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
por: Zhou, Yamei, et al.
Publicado: (2007)

Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells
por: Varma, Hemant, et al.
Publicado: (2007)

An empirical Bayes model for gene expression and methylation profiles in antiestrogen resistant breast cancer
por: Jeong, Jaesik, et al.
Publicado: (2010)

The antiestrogenic effects of black cohosh on BRCA1 and steroid receptors in breast cancer cells
por: Crone, Michael, et al.
Publicado: (2019)

Antiestrogen use reduces risk of cervical neoplasia in breast cancer patients: a population-based study
por: Hsieh, Chia-Jung, et al.
Publicado: (2016)

Gingival cell growth with antiresorptive treatment combined with corticosteroids or antiestrogen
por: Ekholm, Heidi M., et al.
Publicado: (2021)

Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors
por: POP, ANCA, et al.
Publicado: (2015)

Compensatory Estrogen Signal Is Capable of DNA Repair in Antiestrogen-Responsive Cancer Cells via Activating Mutations
por: Suba, Zsuzsanna
Publicado: (2020)

Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER(+) Breast Cancer
por: Servetto, Alberto, et al.
Publicado: (2021)

Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment
por: Larsen, Sarah L., et al.
Publicado: (2015)

Exosome-Mediated Transfer of Cancer Cell Resistance to Antiestrogen Drugs
por: Semina, Svetlana E., et al.
Publicado: (2018)

Resveratrol Sensitizes Tamoxifen in Antiestrogen-Resistant Breast Cancer Cells with Epithelial-Mesenchymal Transition Features
por: Shi, Xiao-Peng, et al.
Publicado: (2013)

Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells
por: Walter, William, et al.
Publicado: (2015)

ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer
por: Zhang, Jianbo, et al.
Publicado: (2017)

G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells
por: Corbet, Andrea K., et al.
Publicado: (2023)

Antiproliferative and Antiestrogenic Activities of Bonediol an Alkyl Catechol from Bonellia macrocarpa
por: Moo-Puc, Rosa, et al.
Publicado: (2015)

Dietary Estrogens Act through Estrogen Receptor-Mediated Processes and Show No Antiestrogenicity in Cultured Breast Cancer Cells.
por: Makela, S, et al.
Publicado: (1994)

Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines
por: Journe, Fabrice, et al.
Publicado: (2006)

Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells
por: Zhang, XinTian, et al.
Publicado: (2012)

Transcriptional regulation prediction of antiestrogen resistance in breast cancer based on RNA polymerase II binding data
por: Zhang, Denan, et al.
Publicado: (2014)

Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor
por: Li, Ye, et al.
Publicado: (2021)

Structural, Thermodynamic, and Kinetic Traits of Antiestrogen-Compounds Selectively Targeting the Y537S Mutant Estrogen Receptor α Transcriptional Activity in Breast Cancer Cell Lines
por: Pavlin, Matic, et al.
Publicado: (2019)

HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells
por: Alam, Muhammad Wasi, et al.
Publicado: (2016)

Design and Synthesis of Novel Breast Cancer Therapeutic Drug Candidates Based upon the Hydrophobic Feedback Approach of Antiestrogens
por: Ohta, Kiminori, et al.
Publicado: (2019)

Breast Cancer Antiestrogen Resistance 3 (BCAR3) – p130(Cas) Interactions Promote Adhesion Disassembly and Invasion in Breast Cancer Cells
por: Cross, Allison M., et al.
Publicado: (2016)

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
por: Larsen, Sarah L, et al.
Publicado: (2015)

Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: A potential new therapeutic approach
por: Santos-Martínez, Nancy, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hm98u1j79tb8jbgrmu514eah7t